Variable epitope library-based COVID-19 vaccine for current and future related epidemics
<p>The outbreak of yet another epidemic (now COVID-19 pandemic) caused by SARS-CoV-2, has reminded the scientific community and, more importantly, the world that in spite of all the financial and human resource investment in vaccine development against major diseases, the success rate has not...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , |
|---|---|
| Μορφή: | Βιβλίο |
| Έκδοση: |
Open Journal of Pharmacology and Pharmacotherapeutics - Peertechz Publications,
2020-04-07.
|
| Θέματα: | |
| Διαθέσιμο Online: | Connect to this object online. |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | peertech__10_17352_ojpp_000011 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Karen Manoutcharian |e author |
| 700 | 1 | 0 | |a Jesus Guzman Valle1 |e author |
| 700 | 1 | 0 | |a Josué Odales |e author |
| 245 | 0 | 0 | |a Variable epitope library-based COVID-19 vaccine for current and future related epidemics |
| 260 | |b Open Journal of Pharmacology and Pharmacotherapeutics - Peertechz Publications, |c 2020-04-07. | ||
| 520 | |a <p>The outbreak of yet another epidemic (now COVID-19 pandemic) caused by SARS-CoV-2, has reminded the scientific community and, more importantly, the world that in spite of all the financial and human resource investment in vaccine development against major diseases, the success rate has not been satisfactory. Accordingly, we must take extraordinary measures to try and contain the spread of this disease and find efficacious treatment options; the generation of prophylactic/therapeutic vaccines may resolve these objectives. </p> | ||
| 540 | |a Copyright © Karen Manoutcharian et al. | ||
| 546 | |a en | ||
| 655 | 7 | |a Short Communication |2 local | |
| 856 | 4 | 1 | |u https://doi.org/10.17352/ojpp.000011 |z Connect to this object online. |